Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted...
Again, just for something different, I thought this looked interesting. Has a habit of quite big runs on positive news. Looks like we might be due sooner or later for the next big one.
Super duper speculative. 100% guessing on this for the fun of it. MACD turned positive, RSI heading up, so never know. Perhaps a rising buy with a trailing sell.
Sorrento Therapeutics, Inc., a commercial and clinically staged biopharmaceutical company, develops therapies for cancerous, autoimmune, inflammatory, viral and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex.
$SRNE announcement during the week positive results of a COVI-MSC study for patients with Post-Covid...
Looks like a cup and handle formation preceeding this potential double bottom. If price action reverses off of $7.70s then im expecting pps to rise dramatically, hopefully breaking past previous highs of $17s.
buy target would be after a rebound off of the drawn support line at 7.73
These are some of my favorites. :-) Enjoy!
The entire forecast is NOT financial advice.
Please speak with multiple professional financial advisors and never invest more than you have available for investments; which can rapidly lose or gain value at different times. All comments below are also NOT financial advice! Please let the viewers know what you think...
This is a Bullish indicator signaling SRNE's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron's A.I.dvisor identified 46 similar cases where SRNE's MACD histogram became positive, and 40 of them led to successful outcomes. Odds of Success: 87%. Current price $9.86 crossed the resistance line at $10.26 and is...
Sorrento Therapeutics, Inc. is a commercial and clinically staged biopharmaceutical company, developing therapies for cancerous, autoimmune, inflammatory, viral and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex.
The company has been constantly adding new options to its bulky pipeline and has made two notable...
As long as the company continues to provide decent news and progress, I believe this pattern will prove itself.
The market went down hard at yesterday's session and recovered strongly, I believe that SRNE weak hands were washed out in that move and now it will be easier for it to move towards the highs.
If the volume goes down and the price will move...
I didn't want to publish this idea, but I put it public in case it comes true. I hope to get the end right.
I'm a beginner and I'm learning so I accept any comments.
No quería publicar esta idea, pero la pongo pública por si se cumple. Espero acertar el final.
Soy novato y estoy aprendiendo así que acepto cualquier comentario al respeto.
My initial predictions of this chart were on. (Downtrend incoming )
Expecting a major hit from SRNE in the upcoming two weeks.
Will be having an eye on this chart on Tuesday!
Price Target of $17.23
If it closes above the price target I am expecting continued healthy growth.
Will then revisit and update the long-term target!
downtrend support held as expected, congrats to dip buyers! consider taking some profits here, big trendline resistance coming into play, dip entry will be around 8-10 imo. goodluck, sorry for the long break guys, please like/follow/comment !